| Metric | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|
| Total revenue | $35.4M+20.4% | $29.4M-31.6% | $43.0M-14.1% | $50.0M |
| Research and development | $253.1M+35.4% | $186.9M+41.4% | $132.3M+44.1% | $91.8M |
| General and administrative | $40.6M+33.3% | $30.4M+42.1% | $21.4M+72.7% | $12.4M |
| Total operating expenses | $293.7M+35.1% | $217.4M+41.5% | $153.7M+47.5% | $104.2M |
| Loss from operations | -$258.3M-37.4% | -$188.0M-69.8% | -$110.7M-104.5% | -$54.1M |
| Interest income | $9.2M+885.4% | $929K-58.5% | $2.2M+2.2% | $2.2M |
| Interest expense | $0+100.0% | -$12K+83.1% | -$71K+33.0% | -$106K |
| Total other income, net | $9.2M+898.3% | $917K-57.7% | $2.2M+4.0% | $2.1M |
| Loss before income taxes | -$249.1M-33.2% | -$187.1M-72.4% | -$108.5M-108.6% | -$52.0M |
| Benefit from income taxes | $420K | $0-100.0% | $371K-91.5% | $4.4M |
| Net loss | -$248.7M-32.9% | -$187.1M-73.0% | -$108.2M-126.9% | -$47.7M |
| Redeemable convertible preferred stock dividends - undeclared and cumulative | $0 | $0+100.0% | -$2.2M | — |
| Net loss attributable to common stockholders | -$248.7M-32.9% | -$187.1M-69.5% | -$110.4M-78.3% | -$61.9M |
| Net loss per share attributable to common stockholders, basic | -$3.08-19.8% | -$2.57-27.9% | -$2.01 | — |
| Net loss per share attributable to common stockholders, diluted | -$3.08-19.8% | -$2.57-27.9% | -$2.01 | — |
| Weighted-average shares used to compute net loss per share attributable to common stockholders, basic | $80626525.00+10.7% | $72806079.00+32.7% | $54874119.00 | — |
| Weighted-average shares used to compute net loss per share attributable to common stockholders, diluted | $80626525.00+10.7% | $72806079.00+32.7% | $54874119.00 | — |
| Collaboration Revenue | ||||
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.